Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

61.12
-0.2300-0.37%
Post-market: 61.120.00000.00%16:23 EDT
Volume:2.38M
Turnover:146.05M
Market Cap:8.50B
PE:-8.51
High:62.05
Open:61.09
Low:60.15
Close:61.35
52wk High:88.31
52wk Low:54.30
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.86
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-48.98
PE(LYR):-9.35

Loading ...

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares Valued at $214,830

Reuters
·
Yesterday

H.C. Wainwright Reaffirms Their Buy Rating on Cytokinetics (CYTK)

TIPRANKS
·
Oct 05

Bumble, PIMCO Dynamic, Cytokinetics, Medifast, Grace

TIPRANKS
·
Oct 03

Cytokinetics to Present Four Aficamten Studies at HFSA Annual Scientific Meeting 2026

Reuters
·
Oct 02

Cytokinetics Announces Four Upcoming Presentations at the Hfsa Annual Scientific Meeting 2026

THOMSON REUTERS
·
Oct 02

H.C. Wainwright Sticks to Its Buy Rating for Cytokinetics (CYTK)

TIPRANKS
·
Sep 30

Cytokinetics Starts Real-World Study of Myqorzo in Obstructive Hypertrophic Cardiomyopathy

MT Newswires Live
·
Sep 30

Cytokinetics Launches Aspen-HCM: a Real-World Study Evaluating Myqorzo® (Aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy

THOMSON REUTERS
·
Sep 30

Top Executive Makes a Bold Move With Recent Cytokinetics Stock Sale

TIPRANKS
·
Sep 29

Cytokinetics CEO Robert I. Blum Disposes of USD 490,950 in Common Shares

Reuters
·
Sep 29

Aspen Aerogels, Sezzle, PIMCO, Kimbell, Cytokinetics Insider Moves

TIPRANKS
·
Sep 26

Top Cytokinetics Executive Makes Notable Stock Move in High-Value Sale

TIPRANKS
·
Sep 23

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of Common Shares Worth $239,015

Reuters
·
Sep 23

Cytokinetics Grants 52,834 Inducement Stock Options at USD 69.31 Strike Price

Reuters
·
Sep 18

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 18

Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program

THOMSON REUTERS
·
Sep 14

Cytokinetics Insider Move Sparks Fresh Investor Buzz

TIPRANKS
·
Sep 12

Cytokinetics Director Robert E. Landry Sells 1,000 Common Shares Worth $74,660

Reuters
·
Sep 12

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live
·
Sep 11